Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

Kampa-Schittenhelm KM, Salitzky O, Akmut F, Illing B, Kanz L, Salih HR, Schittenhelm MM.

BMC Cancer. 2016 Jan 16;16:25. doi: 10.1186/s12885-015-2029-8.


Rapamycin, an mTOR inhibitor, induced apoptosis via independent mitochondrial and death receptor pathway in retinoblastoma Y79 cell.

Wang YD, Su YJ, Li JY, Yao XC, Liang GJ.

Int J Clin Exp Med. 2015 Jul 15;8(7):10723-30. eCollection 2015.


Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Zumbrun EE, Sido JM, Nagarkatti PS, Nagarkatti M.

J Neuroimmune Pharmacol. 2015 Jun;10(2):245-54. doi: 10.1007/s11481-015-9586-0. Epub 2015 Jan 25. Review.


Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.


Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.

Pandey R, Hegde VL, Nagarkatti M, Nagarkatti PS.

J Pharmacol Exp Ther. 2011 Sep;338(3):819-28. doi: 10.1124/jpet.111.182717. Epub 2011 Jun 14.


Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis.

Zhang M, Lee SJ, An C, Xu JF, Joshi B, Nabi IR, Choi AM, Jin Y.

Free Radic Biol Med. 2011 May 15;50(10):1252-62. doi: 10.1016/j.freeradbiomed.2011.02.031. Epub 2011 Mar 5.


β-Elemene piperazine derivatives induce apoptosis in human leukemia cells through downregulation of c-FLIP and generation of ROS.

Yu Z, Wang R, Xu L, Xie S, Dong J, Jing Y.

PLoS One. 2011 Jan 25;6(1):e15843. doi: 10.1371/journal.pone.0015843.


Do cannabinoids have a therapeutic role in transplantation?

Nagarkatti M, Rieder SA, Hegde VL, Kanada S, Nagarkatti P.

Trends Pharmacol Sci. 2010 Aug;31(8):345-50. doi: 10.1016/ Epub 2010 Jun 28. Review.


Cannabinoids as novel anti-inflammatory drugs.

Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M.

Future Med Chem. 2009 Oct;1(7):1333-49. doi: 10.4155/fmc.09.93. Review.


Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

Pandey R, Hegde VL, Singh NP, Hofseth L, Singh U, Ray S, Nagarkatti M, Nagarkatti PS.

Vitam Horm. 2009;81:487-504. doi: 10.1016/S0083-6729(09)81019-4. Review.


Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P.

Immunobiology. 2010 Aug;215(8):598-605. doi: 10.1016/j.imbio.2009.04.001. Epub 2009 May 20. Review.


The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

Supplemental Content

Support Center